Recurring Technology was Health Catalyst’s largest product and service line in fiscal 2025, bringing in $208.28M of $311.14M (67%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Recurring Technology | $175.81M | $187.23M | $194.85M | $208.28M | |||||
| Professional Services | $99.95M | $108.36M | $111.73M | $102.86M | |||||
| One-Time Technology (I.E., Perpetual License) | $480.00K | $357.00K | — | — | |||||
| Total | $276.24M | $295.94M | $306.58M | $311.14M |
Health Catalyst brought in $311.14M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 1.5% from $306.58M in fiscal 2024. Recurring Technology was the largest at $208.28M (66.9%), ahead of Professional Services at $102.86M (33.1%).
Compared with fiscal 2024, Recurring Technology grew 6.9% to $208.28M, while Professional Services fell 7.9% to $102.86M.
Health Catalyst stopped reporting One-Time Technology (I.E., Perpetual License) as a separate line after fiscal 2023, when it brought in $357.00K.
Technology was Health Catalyst’s largest segment in fiscal 2025, bringing in $208.28M of $311.14M (67%).
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Technology | $176.29M | $187.58M | $194.85M | $208.28M | |||||
| Professional Services | $99.95M | $108.36M | $111.73M | $102.86M | |||||
| Total | $276.24M | $295.94M | $306.58M | $311.14M |
Health Catalyst brought in $311.14M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 1.5% from $306.58M in fiscal 2024. Technology was the largest at $208.28M (66.9%), ahead of Professional Services at $102.86M (33.1%).
Compared with fiscal 2024, Technology grew 6.9% to $208.28M, while Professional Services fell 7.9% to $102.86M. From fiscal 2022 to 2025, combined revenue from these segments grew from $276.24M to $311.14M, a compound annual growth rate of 4.0%. Technology's share of the total rose from 63.8% to 66.9%.
Health Catalyst (HCAT) reports its revenue by product and service and by segment. In fiscal 2025, Recurring Technology was its largest product and service line, bringing in $208.28M (66.9% of the total), followed by Professional Services at $102.86M (33.1%).
Recurring Technology was Health Catalyst's largest product and service line in fiscal 2025, bringing in $208.28M, or 66.9% of the $311.14M total across its two product and service lines.
Technology was Health Catalyst's largest segment in fiscal 2025, bringing in $208.28M, or 66.9% of the $311.14M total across its two segments.
Recurring Technology grew faster than Professional Services in fiscal 2025, up 6.9% from $194.85M to $208.28M. Professional Services fell 7.9% to $102.86M.
Every figure comes from Health Catalyst's annual financial filings, as reported. Each line keeps the name Health Catalyst gives it, and years follow its fiscal calendar.
Health Catalyst's revenue by product and service goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.